Ethk Labs

Ethk Labs Current Liabilities

The Current Liabilities of Ethk Labs (1931.HK) as of Nov 3, 2026 is 2.65 B CNY. In the previous year, Current Liabilities was 1.35 B CNY — a change of 97.25% (higher).

Current Liabilities

2.65 BCNY

YoY

97.25%

Last updated:

Current Liabilities of Ethk Labs is 2025 2.65 B CNY. Current Liabilities of Ethk Labs was 2024 1.35 B CNY. It decreases by 97.25% higher compared to the previous year.

The Ethk Labs Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
76.80 M CNY
Jan 1, 2019
1.13 B CNY
Jan 1, 2020
719.47 M CNY
Jan 1, 2021
1.63 B CNY
Jan 1, 2022
1.11 B CNY
Jan 1, 2023
1.05 B CNY
Jan 1, 2024
1.35 B CNY
Jan 1, 2025
2.65 B CNY
The Ethk Labs Current Liabilities history
YEARCurrent LiabilitiesYoY
2.65 BCNY+97.25%
1.35 BCNY+27.75%
1.05 BCNY-5.13%
1.11 BCNY-31.89%
1.63 BCNY+126.60%
719.47 MCNY-36.33%
1.13 BCNY+1,371.21%
76.80 MCNY+23.24%
62.32 MCNY+8.05%
57.68 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ethk Labs Stock analysis

What does Ethk Labs do? IVD Medical Holding Ltd. generates revenue through the sale and manufacture of medical equipment and consumables, primarily focusing on IVD analyzers, reagents, and related consumables. The company's distribution business handles the sales of these products, while its self-branded products business involves developing, producing, and selling its own IVD products. Additionally, the firm offers repair services for its self-branded IVD products, creating a recurring revenue stream from maintenance and support. The company targets healthcare providers and medical facilities that require diagnostic equipment and consumables. Its self-branded IVD products cater to the growing demand for in-house diagnostic solutions, while the distribution segment serves as a key channel for third-party products. Repair services further strengthen customer relationships by ensuring product longevity and reliability. IVD Medical Holding Ltd. operates with a dual revenue model: direct sales of self-branded IVD products and distribution of third-party analyzers and reagents. The company's focus on both manufacturing and distribution allows it to capture value across the diagnostic supply chain, from product development to end-user support. Ethk Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ethk Labs stock

Current Liabilities of Ethk Labs is 2.65 B CNY in 2025.

Current Liabilities of Ethk Labs changed from 1.35 B CNY to 2.65 B CNY, representing a 97.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Ethk Labs since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Ethk Labs historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ethk Labs

All Key Metrics — Ethk Labs